Clinicopathologic significance of urokinase receptor- and MMP-9-positive stromal cells in human colorectal cancer: Functional multiplicity of matrix degradation on hematogenous metastasis

International Journal of Cancer

Volumn 86, Issue 1, 2000, Pages 24-29

  Saito, Kazuya ^a   Takeha, Satoshi ^a,b   Shiiba, Kenichi ^a   Matsuno, Seiki ^a   Sorsa, Timo ^c   Nagura, Hiroshi ^a   Ohtani, Haruo ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^c UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE B; UROKINASE RECEPTOR;

ADULT; AGED; ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; FIBROBLAST; HUMAN; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; STROMA CELL;

BONE NEOPLASMS; COLORECTAL NEOPLASMS; EXTRACELLULAR MATRIX; FEMALE; FIBROBLASTS; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; LUNG NEOPLASMS; MACROPHAGES; MALE; MATRIX METALLOPROTEINASE 9; MICROSCOPY, IMMUNOELECTRON; MIDDLE AGED; NEOPLASM CIRCULATING CELLS; NEOPLASM STAGING; RECEPTORS, CELL SURFACE; RETROSPECTIVE STUDIES; STROMAL CELLS;

EID: 0034102027     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(20000401)86:1<24::AID-IJC4>3.0.CO;2-A     Document Type: Article

References (28)

1. BANCHEREAU, J. and STEINMAN, R.M., Dendritic cells and the control of immunity. Nature (Lond.), 392, 245-252 (1998).
2. DEAR, A.E. and MEDCALF, R.L., The urokinase-type-plasminogen activator receptor (CD87) is a pleiotropic molecule. Europ. J. Biochem., 252, 185-193 (1998).
3. ELLIS, V., PYKE, C., ERIKSEN, J., SOLBERG, H. and DANØ, K., The urokinase receptor: involvement in cell surface proteolysis and cancer invasion. Ann. NY. Acad. Sci., 667, 13-31 (1992).
4. EMMERT-BUCK, M.R., ROTH, M.J., ZHUANG, Z., CAMPO, E., ROZHIN, J., SLOANE, B.F., LIOTTA, L.A. and STETLER-STEVENSON, W.G., Increased gelatinase A (MMP-2) and cathepsin B activity in invasive tumor regions of human colon cancer samples. Amer. J. Pathol., 145, 1285-1290 (1994).
5. GREEN, S.J., CHEN, T.Y., CRAWFORD, R.M., NACY, C.A., MORRISON, D.C. and MELTZER, M.S., Cytotoxic activity and production of toxic nitrogen oxides by macrophages treated with IFN-gamma and monoclonal antibodies against the 73-kDA lipopolysaccharide receptor. J. Immunol., 149, 2069-2075 (1992).
6. GRESS, T.M., MULLER-PILLASCH, F., LERCH, M.M., FRIESS, H., BUHLER, M. and ADLER, G., Expression and in situ localization of genes coding for extracellular matrix proteins and extracellular matrix degrading proteases in pancreatic cancer. Int. J. Cancer, 62, 407-413 (1995).
7. HAMILTON, J.A., PICCOLI, D.S., LEIZER, T., BUTLER, D.M., CROATTO, M., and ROYSTON, A.K., Transforming growth factor beta stimulates urokinase-type plasminogen activator and DNA synthesis, but not prostaglandin E2 production, in human synovial fibroblasts. Proc. nat. Acad. Sci. (Wash.), 88, 7180-7184 (1991).
8. HATANE, T., YOSHIDA, E., KAWANO, J., SUGIKI, M., ONITSUKA, T. and MARUYAMA, M., Prostaglandin 12 analog enhances the expression of urokinase-type plasminogen activator and wound healing in cultured human fibroblast. Bioch. biophys. Acta, 1403, 189-198 (1998).
9. HEPPNER, K.J., MATRISIAN, L.M., JENSEN, R.A. and RODGERS, W.H., Expression of most matrix metalloproteinase family members in breast cancer represents a tumor-induced host response. Amer. J. Pathol., 149, 273-282 (1996).
10. HILDENBRAND, R., DILGER, I., HORLIN, A. and STUTTE, H.J., Urokinase and macrophages in tumour angiogenesis. Brit. J. Cancer, 72, 818-823 (1995).
11. JOHANSSON, N., AIROLA, K., GRENMAN, R., KARINIEMI, A.L., SAARIALHOKERE, U. and KAHARI, V.M., Expression of collagenase-3 (matrix metalloproteinase-13) in squamous cell carcinomas of the head and neck. Amer. J. Pathol., 151, 499-508 (1997).
12. JOHNSON, L.L., DYER, R. and HUPE, D.J., Matrix metalloproteinases. Curr. Opin. chem. Biol., 2, 466-471 (1998).
13. KUMAGAI, K., OHNO, I., OKADA, S., OHKAWARA, Y., SUZUKI, K., SHINYA, T., NAGASE, H., IWATA, K. and SHIRATO, K., Inhibition of matrix metalloproteinases prevents allergen-induced airway inflammation in a murine model of asthma. J. Immunol., 162, 4212-4219 (1999).
14. MIGITA, T., SATO, E., SAITO, K., MIZOI, T., SHIIBA, K., MATSUNO, S., NAGURA, H. and OHTANI, H., Differing expression of MMPs 1 and 9, and urokinase receptor between diffuse-and intestinal-type gastric carcinoma. Int. J. Cancer, 84, 74-79 (1999).
15. MIZOI, T., OHTANI, H., SUZUKI, Y., SHIIBA, K., MATSUNO, S. and NAGURA, H., Intercellular adhesion molecule-1 expression by macrophages in human gastrointestinal carcinoma: possible roles as host immune/inflammatory reaction. Pathol. Int., 45, 565-572 (1995).
16. NORTH, R.J., Down-regulation of the antitumor immune response. Adv. Cancer Res., 45, 1-43 (1985).
17. OHTANI, H., Stromal reaction in cancer tissue: pathophysiologic significance of expression of matrix-degrading enzymes in relation to matrix turnover and immune/inflammatory reactions. Pathol. Int., 48, 1-9 (1998).
18. OHTANI, H., NAGAI, T. and NAGURA, H., Similarities of in situ mRNA expression between gelatinase A (MMP-2) and type I procollagen in human gastrointestinal carcinoma: comparison with granulation tissue reaction. Jpn. J. Cancer Res., 86, 833-839 (1995a).
19. OHTANI, H., NAITO, Y., SAITO, K and NAGURA, H., Expression of costimulatory molecules B7-1 and B7-2 by macrophages along invasive margin of colon cancer: a possible anti-tumor immunity? Lab. Invest., 77, 231-241 (1997).
20. OHTANI, H., PYKE, C., DANØ, K. and NAGURA, H., Expression of urokinase receptor in various stromal cell populations in human colon cancer: immunoelectron microscopical analysis. Int. J. Cancer, 62, 691-696 (1995b).
21. PYKE, C., KRISTENSEN, P., RALFKIAER, E., GRONDAHL-HANSEN, J., ERIKSEN, J., BLASI, F. and DANØ, K., Urokinase-type plasminogen activator is expressed in stromal cells and its receptor in cancer cells at invasive foci in human colon adenocarcinomas. Amer. J. Pathol., 138, 1059-1067 (1991).
22. SATO, H., OKADA, Y. and SEIKI, M., Membrane-type metalloproteinases (MT-MMPs) in cell invasion. Thombosis Haemostasis, 78, 497-500 (1997).
23. SORSA, T. and 13 OTHERS, Activation of type IV procollagenases by human tumor-associated trypsin-2. J. biol. Chem., 272, 21067-21074 (1997).
24. TAKEHA, S., FUJIYAMA, Y., BAMBA, T., SORSA, T., NAGURA, H. and OHTANI, H., Stromal expression of MMP-9 and urokinase receptor is inversely associated with liver metastasis and with infiltrating growth in human colorectal cancer: a novel approach from immune/inflammatory aspect. Jpn. J. Cancer Res., 88, 72-81 (1997).
25. TANAKA, F., UGURA, N. and ABIKO, Y., Stimulation of plasminogen activator/plasmin system in gingival ribroblast cells by oxygen radicals. Arch. oral Biol., 42, 263-270 (1997).
26. UCHIDA, T., YAMASHITA, T., ARAKI, A., WATANABE, H. and SENDO, F., rINF-gamma-activated rat neutrophils induce tumor cell apoptosis by nitric oxide. Int. J. Cancer, 71, 231-236 (1997).
27. VLODAVSKY, I., FRIEDMANN, Y., ELKIN, M., AINGORN, H., ATZMON, R., ISHAI-MICHAELI, R., BITAN, M., PAPPO, O., PERETZ, T., MICHAL, I., SPECTOR, L. and PECKER, I., Mammalian heparanase: gene cloning, expression and function in tumor progression and metastasis. Nature (Med.), 5, 793-802 (1999).
28. YAMASHITA, T., UCHIDA, T., ARAKI, A. and SENDO, F., Nitric oxide is an effector molecule in inhibition of tumor cell growth by rINF-gamma-activated rat neutrophils. Int. J. Cancer, 71, 223-230 (1997).